These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 3525676

  • 1. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL, Duncan RL, Morrison DC.
    J Immunol; 1986 Aug 15; 137(4):1329-35. PubMed ID: 3525676
    [Abstract] [Full Text] [Related]

  • 2. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 15; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 15; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 4. Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.
    O'Hara AM, Moran AP, Würzner R, Orren A.
    Immunology; 2001 Mar 15; 102(3):365-72. PubMed ID: 11298837
    [Abstract] [Full Text] [Related]

  • 5. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P, McRill CM, Ross SC.
    J Immunol; 1988 Dec 01; 141(11):3902-9. PubMed ID: 3141507
    [Abstract] [Full Text] [Related]

  • 6. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
    Ward CK, Inzana TJ.
    J Immunol; 1994 Sep 01; 153(5):2110-21. PubMed ID: 8051416
    [Abstract] [Full Text] [Related]

  • 7. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.
    Leijh PC, van den Barselaar MT, van Zwet TL, Daha MR, van Furth R.
    J Clin Invest; 1979 Apr 01; 63(4):772-84. PubMed ID: 374424
    [Abstract] [Full Text] [Related]

  • 8. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A, Ahmed HJ, Van Dyck E, Lagergård T.
    Microb Pathog; 1998 Aug 01; 25(2):67-75. PubMed ID: 9712686
    [Abstract] [Full Text] [Related]

  • 9. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
    Joiner KA, Goldman R, Schmetz M, Berger M, Hammer CH, Frank MM, Leive L.
    J Immunol; 1984 Jan 01; 132(1):369-75. PubMed ID: 6197449
    [Abstract] [Full Text] [Related]

  • 10. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF, Schmetz MA, Foulds J, Hammer CH, Frank MM, Joiner KA.
    J Immunol; 1987 Feb 01; 138(3):842-8. PubMed ID: 3100618
    [Abstract] [Full Text] [Related]

  • 11. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK, Johnson RC, Dalmasso AP.
    J Immunol; 1991 Jun 01; 146(11):3964-70. PubMed ID: 2033266
    [Abstract] [Full Text] [Related]

  • 12. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T, Frisk A, Purvèn M, Nilsson LA.
    Microb Pathog; 1995 Jan 01; 18(1):37-51. PubMed ID: 7783597
    [Abstract] [Full Text] [Related]

  • 13. Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100.
    Ogata RT, Levine RP.
    J Immunol; 1980 Oct 01; 125(4):1494-8. PubMed ID: 6997381
    [Abstract] [Full Text] [Related]

  • 14. The fate of E. coli lipopolysaccharide after the uptake of E. coli by murine macrophages in vitro.
    Duncan RL, Morrison DC.
    J Immunol; 1984 Mar 01; 132(3):1416-24. PubMed ID: 6363541
    [Abstract] [Full Text] [Related]

  • 15. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    Joiner K, Brown E, Hammer C, Warren K, Frank M.
    J Immunol; 1983 Feb 01; 130(2):845-9. PubMed ID: 6848598
    [Abstract] [Full Text] [Related]

  • 16. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.
    Clas F, Loos M.
    Immunology; 1980 Aug 01; 40(4):547-56. PubMed ID: 6776034
    [Abstract] [Full Text] [Related]

  • 17. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL, Berger M, Hammer CH, Meltzer MS.
    J Immunol; 1985 Jul 01; 135(1):570-4. PubMed ID: 3998474
    [Abstract] [Full Text] [Related]

  • 18. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
    Traub WH, Fukushima PI.
    Zentralbl Bakteriol Orig A; 1979 Dec 01; 245(4):495-511. PubMed ID: 44945
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bactericidal activity of C9-deficient human serum.
    Pramoonjago P, Kinoshita T, Hong KS, Takata-Kozono Y, Kozono H, Inagi R, Inoue K.
    J Immunol; 1992 Feb 01; 148(3):837-43. PubMed ID: 1730876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.